News & Media
Updated Chronic Kidney Disease Screening Measures
There is significant underutilization of chronic kidney disease (CKD) testing in people at risk for CKD. Both estimated Glomerular Filtration Rate (eGFR) and urinary albumin-creatinine ratio (ACR) are important as albuminuria is often detected before the eGFR drops below 60 mL/min/1.73 m2. The National Kidney Foundation (NKF) worked with the National Committee for Quality Assurance to develop a new measure to improve CKD testing in people with diabetes. The Kidney Health Evaluation for Adults with Diabetes (KED) was approved as a first year HEDIS measure for MY2020. The new measure will be applicable to Commercial, Medicaid, and Medicare and assess the percentage of members 18–85 years of age with diabetes (type 1 and type 2) who received a kidney health evaluation, defined by an estimated glomerular filtration rate (eGFR) and a urine albumin-creatinine ratio (uACR), during the measurement year.
The newly revised Michigan Quality Improvement Consortium guideline, “Diagnosis and Management of Adults with Chronic Kidney Disease”, is consistent with the Kidney Health HEDIS measure. http://www.mqic.org/pdf/mqic_diagnosis_and_management_of_adults_with_chronic_kidney_disease_cpg.pdf
Details about the KED can be found in the NCQA blog: https://blog.ncqa.org/kidneyhealth/
For information regarding early identification and management of CKD, please contact Ann Andrews, National Kidney Foundation of Michigan, Senior Program Manager.